0001766140 1 2026-05-22 2026-05-22 0001766140 2 2026-05-22 2026-05-22 0001766140 3 2026-05-22 2026-05-22 0001766140 4 2026-05-22 2026-05-22 0001766140 5 2026-05-22 2026-05-22 0001766140 6 2026-05-22 2026-05-22 0001766140 2026-05-22 2026-05-22 iso4217:USD pure S-3 EX-FILING FEES 0001766140 N/A N/A S-3 Unicycive Therapeutics, Inc. false Equity Common Stock, par value $0.001 per share true false Equity Preferred Stock, par value $0.001 per share true false Debt Debt Securities true false Other Warrants true false Other Units true false Unallocated (Universal) Shelf true 150000000.00 0.0001381 20715.00 150000000.00 20715.00 0.00 20715.00 There are being registered hereunder such indeterminate number of shares of common stock, such indeterminate number of shares of preferred stock, such indeterminate principal amount of debt securities such indeterminate number of warrants to purchase common stock, preferred stock or debt securities, and such indeterminate amount of units, as shall have an aggregate initial offering price not to exceed $150,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $150,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The securities registered also include such indeterminate number of shares of common stock and preferred stock and principal amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder include such indeterminate number of securities as may be issuable with respect to the securities being registered hereunder as a result of stock splits, stock dividends or similar transactions.<br/><br/>The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.F. of Form S-3 under the Securities Act.<br/><br/>Calculated pursuant to Rule 457(o) under the Securities Act.